JG
OLMA icon

Jain Global’s Olema Pharmaceuticals OLMA Stock Holding History

Jain Global’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$242K Buy
+19,324
New +$259K ﹤0.01% 1470
2026
Q1 		– Sell
-30,160
Closed -$754K – 1529
2025
Q4 		$754K Buy
+30,160
New +$537K ﹤0.01% 754
2025
Q2 		– Sell
-12,396
Closed -$46.6K – 1505
2025
Q1 		$46.6K Buy
+12,396
New +$62.3K ﹤0.01% 1008

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Jain Global's OLMA Position: Q2 2026 in Review

Jain Global opened a new position in Olema Pharmaceuticals (OLMA) in Q2 2026: 19,324 shares worth $242K. The stake represents ﹤0.01% of the portfolio and ranks #1470 among its holdings. This is a return to the name: Jain Global previously reported a position in OLMA as recently as Q4 2025.

Jain Global first reported a position in OLMA in Q1 2025 and has held it in 3 quarters since. The position peaked at $754K in Q4 2025. 186 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • Jain Global held 19,324 shares of Olema Pharmaceuticals worth $242K as of Q2 2026.
  • Olema Pharmaceuticals was a new Jain Global position in Q2 2026.
  • Olema Pharmaceuticals made up ﹤0.01% of Jain Global's portfolio in Q2 2026, its #1470 holding.
  • Jain Global first reported a position in Olema Pharmaceuticals in Q1 2025 and has held it in 3 quarters since.
  • Jain Global's Olema Pharmaceuticals position peaked at $754K in Q4 2025.
  • 186 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Jain Global's 13F filing for Q2 2026, filed 14 Aug 2026.